Home › Sickle Cell Disease › NCT07083531
Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait
Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait
Who can join
Ages 50 and older · Women · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Female of African Decent. * Age 50 years or older. * Lack of menstrual period for at least 12 consecutive months Exclusion Criteria: * Taking medications known to influence bone metabolism (e.g., glucocorticoids, hormonal therapy, cancer or chemotherapy meds, anti-resorptive medications or anabolic therapies). * Known metabolic bone disorder (e.g., uncontrolled thyroid disease, hyperparathyroidism, Vitamin D deficiency) * Taking an investigational drug * Documented sickle cell disease
About the study
This is a cross-sectional, clinical research study comparing postmenopausal women of African Descent (AD) with different hemoglobin genotypes: normal and sickle cell trait (SCT). This research study has two purposes. The first purpose is to determine whether having SCT is a risk factor for the development of bone thinning in older women. The second purpose is to investigate whether women with SCT have reduced muscle function and increased frailty compared to women without SCT. The investigators estimate enrolling 50 female volunteers who are at least 50 years old and have not had a menstrual period for at least 12 consecutive months. Volunteers need not know whether they have SCT as this will be evaluated as part of the study.
What is being tested
- Healthy volunteers without SCT (other)
- Healthy volunteers with SCT (other)
Sponsor: UConn Health · Participants: 50 · Started: Aug 23, 2022
Contact the study team
- Zoe Green, BS · Phone: 860.679.4656
Official record on ClinicalTrials.gov — NCT07083531
Locations in the U.S.
| Connecticut | UConn Health, Farmington |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.